Clinical Case Reports

Clinical reports tell us that PCA-Rx is a powerful agent of detoxification. Anyone working in industries with exposures to cadmium, lead, mercury and other toxic metals will find PCA-Rx a powerful health ally. Persons with mercury amalgam dental fillings will also find PCA-Rx beneficial. In future reports, we will report on its uses in many other potential areas of toxic bioaccumulation. But, for now, ets examine several clinical case reports involving mercury contamination from both occupational and dental exposures.

Mercury Poisoning Case #1.

A September 30, 2000 case study bulletin reported on a 53-year-old male who had his dental amalgams removed but was suspected of having toxic levels of heavy metals due to a DMPS urine challenge. This patient also was employed in a profession wherein he was potentially exposed to mercury and copper on a regular basis. According to his doctor he showed “very elevated” levels of mercury at 29 micrograms (mcg) per 24-hour period with a normal reference range of up to only 5 mcg. On this test, no other toxic elements were beyond the reference range. (Urinary testing was by Doctor’s Data and stool analysis was by Great Smokies Diagnostic Laboratory.) The patient was begun on PCA-Rx for approximately nine days. Post-provocation results showed PCA-Rx pulled toxic metals from the body through both the renal (kidney) and bowel systems without patient complaints. In fact, according to testing, PCA-Rx eliminated some 400 percent more arsenic over the pre-test. Stool analysis showed that mercury excretion increased more than 2,650 percent from .009 milligrams per kilogram (mg/kg) to .243 mg/kg. Since urinary mercury excretion was lower on the post-challenge test and stool mercury excretion increased so dramatically, it is clear that the bulk of bound metal was removed through the bowels. Other toxic metals that increased in the stool were arsenic, cadmium, lead, platinum, and thallium.

Mercury Poisoning Case #2.

A 49-year-old female with mercury dental amalgams that were removed in 1997 had previously been on a detoxification protocol utilizing DMPS and other chelators. However, by June 1999, her mercury levels were still very high and measured about 75 parts per billion in her urine with a normal reference range being only up to about three parts per billion. She eventually stopped her detoxification program because, according to the patient, she felt “bad all the time.” Symptomatology included low oral basal temperature between 97.2° and 97.6° F, an increase in weight over the last three to four years, mildly inflamed thyroid gland, swelling in the feet and ankle areas, and abdominal pain. In addition, her menstrual cycles were recently shortened to anywhere from 21 to 24 days. She was put on a detoxification protocol of three doses (consisting of 15 sprays per dose) for the first day and 15 sprays per day for the following four days. On the final day, stool and urine samples were taken and analyzed by Doctor’s Data and Great Smokies Diagnostics Laboratory. Her mercury levels increased by 800 percent in the urine and arsenic levels increased by 230 percent. Mercury levels in her stool increased by 330 percent, arsenic levels increased by 170 percent, beryllium excretion levels increased by 250 percent, and uranium excretion levels increased by 450 percent. It is noteworthy that throughout the detoxification period, the patient reported no complaints or discomfort, whereas she had stopped her previous protocol due to “feeling bad all the time.” This indicates that not only can PCA-Rx effectively remove heavy metals from the system, it is able to do so gently without undue comfort to the patient.

Mercury Poisoning Case #3.

A 38-year-old female was known to be mercury toxic from a DMPS challenge in May 2000. Her amalgam fillings had been removed only two months earlier. Her levels were in the “very elevated” range. In July, pre-challenge urine and stool samples were collected. The patient then took three doses of PCA-Rx the first day and another urine sample was collected the following morning. The patient was then placed on one dose per day for the following four days. On the fifth day, another urine and stool sample was taken. PCA-Rx increased lead excretion in the stool by almost fivefold and increased mercury excretion, also in the stool, by twofold. Urinary excretion also increased for lead, arsenic, tin, and thallium.

Doctors' Prescription

PCA-Rx is a formula that we have researched and found to be a way of dealing with heavy metal toxicity in the least intrusive manner possible. Parents may want to start with PCA-Rx or combine PCA-Rx with other forms of chelation therapy as their doctor recommends. Two versions of the formula are available: PCA-Rx and PCA. The higher-strength PCA-Rx formula is preferred for therapeutic detoxification; it is the formula used clinically. Use PCA for everyday protection. Both formulas are available at natural health centers and pharmacies, and from health professionals.